Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Enoxaparin vs Standard Care for Central Venous Lines in Critically Ill Children
NCT07710482Recruiting
- Sponsor
- Menoufia University
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of enoxaparin in catheter-related thrombosis (CRT) (2 arms), sponsored by Menoufia University. Primary endpoint: Incidence of catheter-related venous thrombosis at 14 days. Started Aug 2026; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT07710482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710482.